MedPath

Herbal Drug for Treatment of Functional Dyspepsia and eradication of Helicobacter pylori(H.pylori) infection.

Phase 2
Conditions
Functional Dyspepsia.
Dyspepsia
Registration Number
IRCT20160721029026N4
Lead Sponsor
Hormozgan Science & Technology Park
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Written consent and complete knowledge about the study; being diagnosed with Functional dyspepsia based on the ROME III criteria; The presence of H.pylori infection based on Stool antigen test.

Exclusion Criteria

The participants’ lack of consent to continue their participation in the study; kidney and liver diseases based on laboratory tests; warning symptoms of gastric and esophageal cancers, other chronic digestive diseases and peptic ulcer disease based on patient history, physical examination, laboratory tests and, if necessary, upper endoscopy.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath